Week 11 Flashcards
What is antithrombotic therapy used for
-suppress coagulation and reduce thrombin formation
-platelet activation is suppresed my anti platelet drugs
-fibrinolytics reduce existing clots that are clogging vens and arteries
the anticoags and anti platelets are preventative and used before the clotting happens
-fibrinolytics are used after clot formation
What is used to prevent thrombosis
anticoagulants and antiplatelets
What is used if open vessel is totally occluded
thrombolysis
coronary angioplasty
What is used for vasodilation
nitrates (similar to nitric oxide which is released by endothelial cells)
CCB- calcium channel blockers (blocks Ca entry into muscle cells of arteries reducing muscle contraction , more effective than nitrates but since Ca is also used by the heart you need to monitor closely when youre on this therapy)
what are the objectives of anticoagulants
-reduce morbidity
-prevents existing thrombi from getting larger
-stops the formation of new thrombi and keeps them localized
How do anticoagulants vary
mode of action
-specificity of use
-time to be effective
-how they are administered
-half life
-method of measurement
-reverse effects in the event of an overdose
what are the mode of actions of anticoagulants
deficiency of active clotting factors
-indirect inhibitors of factors
-direct inhibitors of factors
What is the most common side effect of anticoagulant therapy
uncontrolled bleeding
-fatal bleeding influenced by dose, patient, condition and age
-all anticoags should have a reversal mechanism
how do you decide which anticoagulants to use
short term vs long term
lower the risk or preventing thrombus formation
what conditions is the patient at risk for
What are the Direct Oral Anticoagulants DOAC:
Dabigatran-Direct thrombin Inhibitor
Apixaban, Rivaroxaban, Edoxaban-Direct Factor Xa Inhibitors
-Do not need antithrombin to inhibit thrombin
Direct Action by:
Prevent conversion of fibrinogen to fibrin
Or prevent activation of thrombin
When is heparin used
in hospital /surgery
bridging to Coumadin or DOACs
immediate effect
IV administration
-look at APTT when monitoring
-to check for specific Hep concentration look at FXa assay
-has a reversal protocol
-therapy for DVT, PR, and MI
targets FXa and FII
along with LMWH and fondaparinux
When are Coumadin or DOAC used
long term use at home depending on condition
-oral administration
DOACs dont need monitoring but it does effect lab tests so you need to see if they are in the pt system . they are antagonist to Thrombin or FX. Reversal protocol are just coming out
What does coumadin do
listen to lecture for this
prevents post VTE rethrombosis, recurrence of DVT
prevents ischemic stroke
targets all Vit K dependent factors
-monitor with PT/INR PTT and Xa assay
-has a reversal protocol
-known as Warfarin
Oral vitamin K antagonist
What does aspirin do
prevents acute coronary syndrome recurrence
antiplatelet inhibitor
What does rivoraxaban /Apixaban do
prevents ischemic stroke
prevents thrombosis after surgery
Oral direct anti Xa
What does dabigatran do
prevents ischemic stroke
targets thrombin FII
What is the mode of action of Coumadin
-Vitamin K antagonist
-suppresses Vitamin K reductase activity
-prevents factor carboxylation
-Vitamin K dependent factors are FII, FVII, FIX, FX and factors C & S
how was coumadin discovered
moldy sweet clover
when cows died after eating them
also used a rat poison but in different dose and form
why do we need to monitor Coumadin
listen for graph explanation
Factor FVII - vitamin K dependent factor has the shortest half life = PT monitoring we will see it prolonged upon administration (PT done 24 hours after starting therapy and checked daily until target is reached then every 4 weeks until therapy is done - 6 months)
PTT will also be prolonged eventually but its half life isnt as sensitive to dose changes like PT and FVII so its not used for coumadin therapy
Protein C has the same half life and helps to regulate coagulation during the first 3 days the pt can be at thrombotic risk if deficient so you need use Heparin to help bridge the crossover until coumadin takes effect
FII and FX have highest; 2 is highest
monitor with PT/INR
how to calculate INR
-looks at Variation in thromboplastin reagents and different instrumentation
INR (pt PT/mean of PT range) ^ISI
What is ISI
International Sensitivity Index »_space; Indicates how sensitive the reagent is to deficiencies in Vit K factors compared to the WHO reference standard reagent
We want it to be as close to 1.0 as we can
What are the side effects of coumadin therapy
affects inflammatory risk
Clotting / Hemorrhage risk
INR < 2 – still risk of Thrombosis
INR 3 – 5: no significant bleeding
INR 5 – 9: high risk for bleeding (surgery)
> 9: serious bleeding
Urticaria- skin lesions, hives
Alopecia- hair loss
Skin necrosis (initial deficiency in Protein C- bridge with heparin and wait until coumadin takes effect)
What are the pitfalls in courmadin therapy
-diet must be high in VitK (reduces INR)
monitoring must be regular
drug interference
Coumadin is metabolized with Cytochrome C50 pathway in liver so any drug who also uses this pathway can affect coumadin - metronidazole affects INR
polymorphism of enzymes
one type slows coumadin breakdown
one slows Vit K reduction making pt more sensitive to coumadin
can POCT be used as the only monitoring method
no because it doesnt always match the plasma tests
-pts should not adjust dose only DRs
-can be used to establish a trend , if there is deviation then the DR can order plasma test